Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

PLA2G7 Antikörper (AA 22-441)

Lp-PLA2 Reaktivität: Human WB, IHC, IP, ICC Wirt: Maus Monoclonal D5 unconjugated
Produktnummer ABIN7426094
  • Target Alle PLA2G7 (Lp-PLA2) Antikörper anzeigen
    PLA2G7 (Lp-PLA2) (Lipoprotein-Associated phospholipase A2 (Lp-PLA2))
    Bindungsspezifität
    • 15
    • 7
    • 7
    • 6
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 22-441
    Reaktivität
    • 54
    • 21
    • 15
    • 15
    • 15
    • 2
    • 1
    Human
    Wirt
    • 45
    • 15
    • 1
    • 1
    Maus
    Klonalität
    • 46
    • 16
    Monoklonal
    Konjugat
    • 24
    • 8
    • 8
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser PLA2G7 Antikörper ist unkonjugiert
    Applikation
    • 47
    • 25
    • 18
    • 13
    • 13
    • 8
    • 6
    • 5
    • 3
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
    Verwendungszweck
    Monoclonal Antibody to Phospholipase A2 Group VII (LpPLA2)
    Spezifität
    The antibody is a mouse monoclonal antibody raised against LpPLA2. It has been selected for its ability to recognize LpPLA2 in immunohistochemical staining and western blotting.
    Aufreinigung
    Protein A + Protein G affinity chromatography
    Immunogen
    Recombinant Phospholipase A2 Group VII (LpPLA2) corresdonding to Phe22~Asn441 with N-terminal His Tag
    Klon
    D5
    Isotyp
    IgG1 kappa
    Top Product
    Discover our top product Lp-PLA2 Primärantikörper
  • Applikationshinweise

    Western blotting: 0.5-2 μg/mL

    1:500-2000 Immunohistochemistry: 5-20 μg/mL

    1:50-200 Immunocytochemistry: 5-20 μg/mL

    1:50-200 Optimal working dilutions must be determined by end user.

    Kommentare

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
    Haltbarkeit
    24 months
  • Target
    PLA2G7 (Lp-PLA2) (Lipoprotein-Associated phospholipase A2 (Lp-PLA2))
    Andere Bezeichnung
    Phospholipase A2 Group VII (Lp-PLA2 Produkte)
    Synonyme
    LDL-PLA2 antikoerper, LP-PLA2 antikoerper, PAFAD antikoerper, PAFAH antikoerper, Lp-PLA2 antikoerper, PAF-AH antikoerper, R75400 antikoerper, zgc:77563 antikoerper, phospholipase A2 group VII antikoerper, phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) antikoerper, PLA2G7 antikoerper, Pla2g7 antikoerper, pla2g7 antikoerper
    Hintergrund
    PLA2G7, PAF-AH, PAFAH, Lp-PLA2, LDL-PLA2, Platelet Activating Factor Acetylhydrolase,Plasma, Phospholipase A2,Group VII, LDL-associated phospholipase A2, Phospholipase A2, Lipoprotein Associated
    Pathways
    Peptide Hormone Metabolism
Sie sind hier:
Kundenservice